High-density lipoprotein heterogeneity and function in reverse cholesterol transport.
about
Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discoveryStructural basis for distinct functions of the naturally occurring Cys mutants of human apolipoprotein A-INew insights into the determination of HDL structure by apolipoproteins: Thematic review series: high density lipoprotein structure, function, and metabolismA new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretionAnti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cellsMolecular mechanisms of cellular cholesterol effluxA computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolismAn in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathwayMicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteinsMacrophages in the pathogenesis of atherosclerosisNovel Methods of Enhanced Retention in and Rapid, Targeted Release from Liposomes.Serum Concentration of HDL Particles Predicts Mortality in Acute Heart Failure Patients.Lipid, blood pressure and kidney update 2013.Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetesHomeostasis of free cholesterol in the blood: a preliminary evaluation and modeling of its passive transport.Immunochemical Approach for Monitoring of Structural Transition of ApoA-I upon HDL Formation Using Novel Monoclonal AntibodiesApolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural FeaturesMouse, but not human, ApoB-100 lipoprotein cholesterol is a potent innate inhibitor of Streptococcus pneumoniae pneumolysin.Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I.An experimentally robust model of monomeric apolipoprotein A-I created from a chimera of two X-ray structures and molecular dynamics simulationsAging affects high-density lipoprotein composition and function.Human apolipoprotein A-I is associated with dengue virus and enhances virus infection through SR-BI.Mitochondria-targeting particles.Glycine dimerization motif in the N-terminal transmembrane domain of the high density lipoprotein receptor SR-BI required for normal receptor oligomerization and lipid transport.HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilutionQuantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia.Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathwayHigh-density lipoprotein particle concentration and subclinical atherosclerosis of the carotid arteries in Japanese men.ABCA1 rs4149313 polymorphism and susceptibility to coronary heart disease: a meta-analysis.Uremia alters HDL composition and functionConformational transitions in the membrane scaffold protein of phospholipid bilayer nanodiscsImpact of self-association on function of apolipoprotein A-IDisruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levels.A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterolSpecific cellular incorporation of a pyrene-labelled cholesterol: lipoprotein-mediated delivery toward ordered intracellular membranesHelix stabilization of amphipathic peptides by hydrocarbon stapling increases cholesterol efflux by the ABCA1 transporter.Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesionsThermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL.
P2860
Q21285000-0F6B553D-58B1-4CCB-9703-E90704AEEE6EQ26823046-A3C508C0-BF9B-425A-B996-888D09AB7D5DQ26851804-23002DDF-C893-4246-811B-085C30B45F95Q26865600-FACEBEC0-33A5-46D5-8235-84EF338A9056Q27012536-0F671DB2-0669-4B17-AAEA-84562B88658AQ27021139-2A001756-02D1-42BF-853D-A911FC27BB09Q28538300-72B53403-70D9-4DC3-A1C8-06AB605CA26EQ28540807-0209702D-7665-489B-8A8C-F92C17185F79Q29615034-7FB11179-4AAA-44C7-B675-14A67794E71AQ29617765-5B0ECA0F-87F9-4754-B295-51CBDECE7EA9Q30466993-24D39387-C401-4139-AE3B-BCEF1FEB2E34Q33572720-D666EBFF-3997-4E90-A86B-47249345AC6AQ33574532-44348FBE-3D42-48DA-BDFB-4AD6531D1A49Q33643266-30C7590F-0CA2-4895-A145-51FD14BB965DQ33653598-5484F7E0-501D-4C16-8136-08A39F160AB0Q33774419-D20AA1E7-8C2A-455D-9129-909F80F16B12Q33813945-1B06329E-5241-4202-8806-ADD715552F30Q34134769-C156E452-15C8-45F0-9345-7071596B50ECQ34155049-872431F3-B3CF-4192-95F4-4553789517BAQ34238652-02C87B31-0994-4D89-89D6-814224404965Q34680298-B253EB93-8B08-4EA3-BD54-A79C4D04322DQ34781392-1924C1E9-77E3-4589-8955-478CA96C69BDQ34876325-F3B7A718-DE6E-4A37-9637-EC2B450A0FC2Q34960940-560A7EA9-DB11-482F-941C-11F724571B11Q34998020-C2C9E5DF-F46F-4FC8-AE59-E77E695C75C5Q35001010-60CD188B-1F13-4945-9AC8-1CBA647E6FF9Q35051225-F0B0538F-E7A4-4BCA-9846-A536B0933B12Q35152189-CCE5B881-94F5-4120-877F-7BD979EC373CQ35166941-FF5FC10A-A791-44BE-9A55-10EB37F97482Q35181281-0EA817EC-18AE-44A9-96D1-89E9E6CD95AFQ35190580-3B06E248-237D-4E46-8210-4F20FD397008Q35210194-966F111F-3CB1-433B-A356-47EAA29F9DE2Q35264725-5682E53C-1C93-4CB7-B1DF-5F44EBD520E3Q35371440-2A5AFC98-760D-4626-84B7-B89BBF9EB6FCQ35380116-28B492E3-3317-4802-B1F9-3CD254B5BCC3Q35561997-483B5022-EDF7-44E9-A8C5-2E51365D7819Q35602305-13314E43-FE2A-486E-AABA-49D8CCB5FD00Q35660283-614ED662-DC8A-4E06-ADD8-1847EA4FB064Q35838851-6E2DD282-87E0-428B-B469-D2B5B30421CBQ35886290-1FF3D343-40B1-4246-856D-BD0889A524F8
P2860
High-density lipoprotein heterogeneity and function in reverse cholesterol transport.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High-density lipoprotein heterogeneity and function in reverse cholesterol transport.
@ast
High-density lipoprotein heterogeneity and function in reverse cholesterol transport.
@en
type
label
High-density lipoprotein heterogeneity and function in reverse cholesterol transport.
@ast
High-density lipoprotein heterogeneity and function in reverse cholesterol transport.
@en
prefLabel
High-density lipoprotein heterogeneity and function in reverse cholesterol transport.
@ast
High-density lipoprotein heterogeneity and function in reverse cholesterol transport.
@en
P2860
P1476
High-density lipoprotein heterogeneity and function in reverse cholesterol transport
@en
P2093
George H Rothblat
P2860
P304
P356
10.1097/MOL.0B013E328338472D
P577
2010-06-01T00:00:00Z